Jason Norris

Vice President and Treasurer at Lapix Therapeutics.

Raised on Lapix Therapeutics filings

$7.7M

of $11M offered across 2 Form D filings

Company

Biotech · Boston, MA

Oral drugs that restore immune tolerance in autoimmunity

Oral drugs that restore immune tolerance in autoimmunity

Lapix Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Aug 5, 2025	Other	$2.2M/ $5M	Form D
Feb 10, 2025	Equity	$5.5M/ $6M	Form D/A

Also named on Lapix Therapeutics filings